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BACKGROUND 
• Axillary lymph node dissection is an integral part of modified radical 
mastectomy which is the prime modality of treatment for curable breast 
cancer 
• Post mastectomy lymphorrhoea is a disabling morbidity with no definite 
cure in the horizon 
• Octreotide is a synthetic somatostatin analogue with general antisecretory 
effects that is used to control lymphorrhea in thoracic duct injury and 
after radical neck dissection 
 
AIM 
• The aim of the study is to find if octreotide has a role in the treatment of 
post axillary lymphadenectomy lymphorrhea. 
PLACE OF STUDY: government stanley medical college hospital 
DURATION: november 2016 to september 2017 
 
STUDY DESIGN: 
• This is a prospective randomized controlled trial. 
• Number of subjects : 50 
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• Randomly allotted to  
Treatment group 25 
Control group 25 
INCLUSION CRITERIA: 
All female patients diagnosed to have carcinoma breast within the age 
group of 30yrs to 80yrs who underwent modified radicle mastectomy 
were included 
EXCLUSION CRITERIA: 
Patients with the following comorbidities were excluded: 
 Diabetes 
 Hepatobiliary disease 
 Thyroid disorders 
 Cardiac diseases 
 Pancreatitis 
 Patients with allergy to octreotide 
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METHOLOGY: 
• The treatment group received0.1 mg octreotide subcutaneously thrice 
daily for 5 consecutive days, starting on the first postoperative day,  
• The control group did not receive any treatment.  
• The fluid in the axillary suction drain(secured in the intra op period) is 
measured in milliliters from post operative day 1, for 10 consecutive days 
for both the treatment and control groups. If there was > 30ml collection 
in the drain for three successive days then the drain was removed before 
the tenth day 
• The day of removal of the drain was also taken in to consideration 
• The fluid was confirmed to be lymph through biochemical tests 
• The control group and the treatment group were evaluated for amount and 
duration of lymphorrhea . 
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ANALYSIS: 
Mean quantity and duration of lymphorrhea in control and treatment 
group are compared 
 
SIMILAR STUDY: 
A prospective randomised controlled trail done by paolo carcoforo et al 
followed 261 patients with various stages of breast cancer who underwent 
axillary dissection for seven years of these 136 was taken as control 
group and 125 as treatment group.The treatment group was given 0.1 mg 
octreotide subcutaneous for thrice daily for 5 days 
 control treatment P value 
Quantity of 
lymphorrhea 
94.6±19 cc per 
day 
65.4 ±21.1cc per 
day 
<o.ooo1 
Duration of 
lymphorrhoea 
16.7 ± 3 days 7.1 ± 2.9 days <0.0001 
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CONCLUSION 
From this study it is evident that octreotide and its analogues have a promising 
role in the treatment of post mastectomy lymphorrea. Since lymphorrhoea leads 
to chronic lymphoedema which inturn predisposes to lymphangiosarcoma,it is 
safe to assume that  the use of octreotide also reduces the risk of incidence of 
this malignancy .similarly octreotide can also be tried in other conditions were 
lymphorrhoea is troublesome like in inguinal lymph node dissection ,peripheral 
vascular surgery.Though octreotide is a promising drug  several more clinical 
trails have to be undertaken before bringing it into mainstream  practice for 
better understanding of the drug’s pharmacodynamics and its rare but serious 
side effects. 
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Proforma 
Name:   Age:   Sex:    IP No. 
RFT –  
Urea:     
Creatinine: 
 RBS 
LFT –  
 Total Bilurubin: 
 SGOT: 
 SGPT: 
 ALP:  
 Sr. Amylase 
 Sr. Lipase 
TFT  
 FT3 
 FT4 
 TSH 
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Stage of Ca Breast: 
Neoadjuvant Chemo/Radiotherapy:  
Quantity of Lymph Drained:  
  Day 1:   Day 6: 
  Day 2:   Day 7: 
  Day 3:   Day 8: 
  Day 4:   Day 9: 
  Day 5:   Day 10: 
Day of Removal of Drain: 
 
 
 
 
 
 
